The current stock price of APR is 37.5 null. In the past month the price increased by 0.43%. In the past year, price increased by 32.23%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.37 | 98.80B | ||
| CI | THE CIGNA GROUP | 9.56 | 72.52B | ||
| LH | LABCORP HOLDINGS INC | 16.77 | 21.99B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.53 | 21.31B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 116.62 | 21.07B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.33B | ||
| DVA | DAVITA INC | 12.95 | 8.54B | ||
| HIMS | HIMS & HERS HEALTH INC | 69.96 | 8.54B | ||
| CHE | CHEMED CORP | 19.84 | 6.36B | ||
| RDNT | RADNET INC | 222.32 | 6.50B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 34.54 | 6.24B | ||
| OPCH | OPTION CARE HEALTH INC | 20.08 | 4.86B |
Apria, Inc. engages in the provision of healthcare services. The company is headquartered in Indianapolis, Indiana and currently employs 6,080 full-time employees. The company went IPO on 2021-02-11. The firm offers a range of products and services for in-home care and delivery across three core service lines, which includes home respiratory therapy (including home oxygen and non-invasive ventilation (NIV) services); obstructive sleep apnea (OSA) treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services) and negative pressure wound therapy (NPWT). Additionally, the Company supplies a range of home medical equipment and other products and services for patients with home care needs. The company also provides a variety of clinical and administrative support services and related products and supplies. The company offers in-home delivery, set-up, and maintenance of equipment and/or supplies; monitoring therapy compliance and intervening to enhance compliance and processing claims to payors on behalf of patients.
APRIA INC
7353 Company Drive
Indianapolis INDIANA 46237 US
CEO: Daniel J. Starck
Employees: 6080
Phone: 18009909799.0
Apria, Inc. engages in the provision of healthcare services. The company is headquartered in Indianapolis, Indiana and currently employs 6,080 full-time employees. The company went IPO on 2021-02-11. The firm offers a range of products and services for in-home care and delivery across three core service lines, which includes home respiratory therapy (including home oxygen and non-invasive ventilation (NIV) services); obstructive sleep apnea (OSA) treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services) and negative pressure wound therapy (NPWT). Additionally, the Company supplies a range of home medical equipment and other products and services for patients with home care needs. The company also provides a variety of clinical and administrative support services and related products and supplies. The company offers in-home delivery, set-up, and maintenance of equipment and/or supplies; monitoring therapy compliance and intervening to enhance compliance and processing claims to payors on behalf of patients.
The current stock price of APR is 37.5 null. The price increased by 0.03% in the last trading session.
APR does not pay a dividend.
APR has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
9 analysts have analysed APR and the average price target is 39.1 null. This implies a price increase of 4.27% is expected in the next year compared to the current price of 37.5.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on APR.
APRIA INC (APR) currently has 6080 employees.
ChartMill assigns a technical rating of 9 / 10 to APR. When comparing the yearly performance of all stocks, APR is one of the better performing stocks in the market, outperforming 92.29% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to APR. While APR has a great profitability rating, there are quite some concerns on its financial health.
Over the last trailing twelve months APR reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS increased by 29.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.66% | ||
| ROA | 8.36% | ||
| ROE | 163.17% | ||
| Debt/Equity | 8.58 |
9 analysts have analysed APR and the average price target is 39.1 null. This implies a price increase of 4.27% is expected in the next year compared to the current price of 37.5.
For the next year, analysts expect an EPS growth of 5.86% and a revenue growth 5.14% for APR